Study Title
Multicentric Phase III Trial Comparing Two Strategies in Intermediate-risk Differentiated Thyroid Cancer Patients: Systematic Radioiodine Administration Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up Based on Serum Tg Values and Diagnostic RAI Scintigraphy
Study Details
Description:
This trial is comparing two strategies in intermediate-risk differentiated thyroid cancer patients: Systematic radioiodine administration versus decision of radioiodine treatment guided by a post-operative work-up based on serum Tg values and diagnostic RAI scintigraphy
Sponsor:
Centre Francois Baclesse
Contacts:
Stéphane BARDET, MDs.bardet@baclesse.unicancer.fr
(33)231455050
Government Study Link:
NCT04290663 - Click here to see study onClinicalTrials.gov